Medical pleated masks market seen growing to $2.49B by 2030

The Business Research Company says the medical pleated masks market will rise from $1.77 billion in 2025 to $1.9 billion in 2026, with growth tied to respiratory disease demand, e-commerce expansion and higher filtration standards. The report also projects the market will reach $2.49 billion by 2030, with Asia-Pacific as the largest regional market in 2025.

Why it matters: - Medical pleated masks remain a core infection-control product as respiratory disease prevalence, public health awareness and distribution channels continue to expand. - The market’s growth signals ongoing demand for disposable surgical masks, reusable options and higher-filtration products across hospitals, pharmacies, homes and commercial settings.

What happened: - The Business Research Company published a Medical Pleated Masks Market Report 2026 covering market size, trends and global forecasts for 2026-2035. - The report puts the market at $1.77 billion in 2025 and forecasts $1.9 billion in 2026, implying 7.3% annual growth. - The same report projects the market will reach $2.49 billion by 2030 at a 7.0% CAGR. - Asia-Pacific was the largest regional market in 2025.

The details: - The report links historic growth to mask shortages during pandemics, strong reliance on hospital and retail pharmacy channels, limited variety in mask types, higher infection-prevention awareness and adoption of ear loop and tie-on designs. - Future growth is expected to come from high-filtration N95 and surgical masks, rising home and commercial use, online pharmacy and e-commerce expansion, regulatory support for sustainable and reusable masks, and comfort and breathability improvements. - The report says key trends include stronger demand for disposable surgical masks, wider adoption of reusable masks, more online and retail distribution, and greater focus on filtration efficiency and wearer comfort. - Medical pleated masks, also called surgical masks, are disposable, loose-fitting masks that cover the nose, mouth and chin. - The masks use multiple fabric layers with pleats that expand for a better fit. - The masks are designed to help block large respiratory droplets and reduce transmission risk by filtering airborne particles and limiting pathogen inhalation. - The report identifies growing respiratory disease prevalence as a major demand driver. - The report cites Australian Institute of Health and Welfare data from June 2024 showing about 8.5 million Australians, or 34% of the population, live with chronic respiratory conditions. - The same data shows about 2.8 million Australians have asthma and 638,000 have COPD. - The report covers Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East and Africa. - The company offers a free sample of the report and the full market report.

Between the lines: - The forecast suggests the market is moving from pandemic-driven demand toward steadier, broader use tied to chronic respiratory illness and everyday infection-control habits. - The emphasis on e-commerce, comfort and reusable designs points to a market competing on convenience as much as protection. - Asia-Pacific’s lead suggests manufacturing, population scale and public-health demand remain important advantages in the region.

What's next: - The market will likely be shaped by filtration upgrades, distribution shifts and regulatory pressure around sustainability through 2030. - Demand may stay resilient if respiratory disease rates, consumer caution and pharmacy/e-commerce access continue to rise. - The report’s expanded 2026 edition adds market attractiveness scoring, TAM analysis, company scoring matrices, Excel forecasting dashboards, hotspot infographics and updated graphics and tables.